Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Hematology, Oncology Clinical Trial
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Status: Enrolling
Updated: 3/2/2011
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
Status: Enrolling
Updated: 3/2/2011
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Marshfield, WI
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Mt. Pleasant, SC
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Norwich, CT
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Peoria, IL
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Pottstown, PA
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Neoplasms, Breast Clinical Trial
EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Status: Enrolling, Phase IV
Updated: 4/4/2016
Novartis Investigative Site
mi
from
Waterloo, IA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling, Phase
Updated: 12/31/1969
Hollings Cancer Center at Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Genetic Epidemiology of Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer
Status: Enrolling, Phase III
Updated: 10/28/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
Status: Enrolling
Updated: 11/6/2012
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cancer Clinical Trial
Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 1/25/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Legacy Emanuel Hospital and Health Center and Children's Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Mattel Children's Hospital at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
CCOP - Florida Pediatric
mi
from
Tampa, FL
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Walter Reed Army Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
MetroHealth Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Lahey Clinic Medical Center - Burlington
mi
from
Burlington, MA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Union Hospital of Cecil County
mi
from
Elkton MD, MD
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Green Bay Oncology Limited at Saint Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Hopedale Medical Complex
mi
from
Hopedale, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Independence Regional Health Center
mi
from
Independence, MO
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Dickinson County Healthcare System
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Joliet Oncology-Hematology Associates, Limited - West
mi
from
Joliet, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
St. Joseph Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Nevada Cancer Research Foundation CCOP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
St. Rita's Medical Center
mi
from
Lima, OH
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Green Bay Oncology - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Illinois CancerCare-Ottawa Clinic
mi
from
Ottawa, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Seton Cancer Institute at Saint Mary's - Saginaw
mi
from
Saginaw, MI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Hematology and Oncology Associates of Northeastern Pennsylvania
mi
from
Scranton, PA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Shawnee Mission Medical Center
mi
from
Shawnee Mission, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Frederick R. and Betty M. Smith Cancer Treatment Center
mi
from
Sparta, NJ
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Baystate Regional Cancer Program at D'Amour Center for Cancer Care
mi
from
Springfield, MA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
St. Joseph, MI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Regions Hospital Cancer Care Center
mi
from
St. Paul, MN
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Green Bay Oncology - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
CCOP - Scott and White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Medical Oncology and Hematology Associates - West Des Moines
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Cancer Center of Kansas
mi
from
Wichita, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Wichita CCOP
mi
from
Wichita, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Susquehanna Cancer Center at Divine Providence Hospital
mi
from
Williamsport, PA
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KS
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Status: Enrolling, Phase II
Updated: 3/15/2011
Marshfield Clinic - Wisconsin Rapids Center
mi
from
Wisconsin Rapids, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 3/19/2014
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 3/19/2014
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 3/19/2014
Sidney Kimmel Cancer Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Status: Enrolling
Updated: 2/11/2013
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Thymoma Clinical Trial
Preoperative Treatment of Patients With High Risk Thymoma
Status: Enrolling, Phase II
Updated: 11/29/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
Status: Enrolling
Updated: 7/22/2009
UPMC Cancer Center - New Castle
mi
from
New Castle, PA
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Combination Chemotherapy and Bevacizumab in Treating Patients With Recurrent, Unresectable, or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, or Esophageal Cancer
Status: Enrolling
Updated: 7/7/2009
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Depression Screening in Patients With Lung Cancer
Status: Enrolling
Updated: 10/14/2010
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 11/6/2012
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 11/6/2012
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Cannot Be Removed By Surgery
Status: Enrolling, Phase II
Updated: 1/27/2010
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Multiple Myeloma and Plasma Cell Neoplasm Clinical Trial
Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
Status: Enrolling
Updated: 7/3/2010
Veterans Affairs Medical Center - Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
E7389 and Cisplatin in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/16/2012
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
E7389 and Cisplatin in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/16/2012
Veterans Affairs Outpatient Clinic - Martinez
mi
from
Martinez, CA
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
E7389 and Cisplatin in Treating Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 2/16/2012
City of Hope Medical Group Inc
mi
from
Pasadena, CA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
Status: Enrolling
Updated: 11/5/2010
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials